The abstract is read at the publisher; the summary is JClub's.
In a longitudinal cohort of 55 WNV lineage 1-infected blood donors, neutralizing antibodies show biphasic decay with half-lives of 37 days and 472 days over 1 year.
- Why it matters: Natural WNV immunity must be understood for vaccine design, especially because no approved therapeutics or vaccines exist and cross-lineage protection may be limited.
- What they did: The study measured WNV-specific binding and neutralizing antibodies longitudinally up to 1 year and fit a biphasic decay model; it also tested lineage 2 cross-reactivity.
- The result: Lineage 1-immune sera had reduced, highly variable neutralizing activity against an emerging divergent lineage 2 strain during both acute and convalescent phases, corroborated in an independent Italy cohort.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.